tiprankstipranks
Trending News
More News >
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
US Market

Cumberland Pharmaceuticals (CPIX) Financial Statements

Compare
227 Followers

Cumberland Pharmaceuticals Financial Overview

Cumberland Pharmaceuticals's market cap is currently $45.02M. The company's EPS TTM is $-0.094; its P/E ratio is -20.99; Cumberland Pharmaceuticals is scheduled to report earnings on March 3, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 44.52M$ 37.87M$ 39.55M$ 42.01M$ 35.99M
Gross Profit$ 37.85M$ 31.28M$ 33.49M$ 32.89M$ 27.17M
Operating Income$ -2.79M$ -6.43M$ -9.55M$ -5.70M$ -7.68M
EBITDA$ 2.49M$ 182.42K$ 2.49M$ 332.92K$ -857.83K
Net Income$ -2.84M$ -6.48M$ -6.28M$ -5.57M$ -3.51M
Balance Sheet
Cash & Short-Term Investments$ 11.44M$ 17.96M$ 18.32M$ 19.76M$ 27.04M
Total Assets$ 76.82M$ 75.58M$ 81.78M$ 92.93M$ 84.46M
Total Debt$ 10.18M$ 20.57M$ 18.43M$ 20.96M$ 16.06M
Net Debt$ -1.26M$ 2.61M$ 106.86K$ 1.20M$ -10.98M
Total Liabilities$ 52.28M$ 53.04M$ 52.52M$ 56.95M$ 41.86M
Stockholders' Equity$ 24.88M$ 22.85M$ 29.60M$ 36.27M$ 42.81M
Cash Flow
Free Cash Flow$ 4.83M$ -791.90K$ 5.64M$ 6.38M$ 5.99M
Operating Cash Flow$ 4.93M$ -612.19K$ 6.09M$ 8.45M$ 6.34M
Investing Cash Flow$ -4.71M$ 57.84K$ -105.69K$ -13.67M$ -501.89K
Financing Cash Flow$ -6.75M$ 196.90K$ -7.42M$ -2.06M$ -3.55M
Currency in USD

Cumberland Pharmaceuticals Earnings and Revenue History

Cumberland Pharmaceuticals Debt to Assets

Cumberland Pharmaceuticals Cash Flow

Cumberland Pharmaceuticals Forecast EPS vs Actual EPS